2023年 3月の投稿一覧

2023.03.13

Announcement of 2023 Drug Price Revision in Japan

The 2023 revision of drug prices in Japan has been announced,

続きを読む

2023.03.13

The 3rd PD-1 Inhibitor, LIBTAYO, approved in Japan

Sanofi’s LIBTAYO, Cemiplimab IV, was approved in December 2022

続きを読む

2023.03.13

HAE Product, BERINERT SC, Listed in NHI Pricing List

CSL Behring’s BERINERT SC was approved for prevention of acute hereditary angioedema attacks, HAE, in September 2022.

続きを読む